AwardedPRTGoods€259,147
2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS]
- Published
- Published 21 October 2025
Overview
DURVALUMAB [50 MG/ ML 10 ML FRS]
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €259,147
- Procedure
- Selective
- Published
- 21 October 2025
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- €259,147
- Award date
- 10 September 2025
- Contract period
- — → 9 March 2026
- ASTRAZENECA- PROD.FARM LDA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
21 October 2025
Contracting authority
Unidade Local de Saúde Santa Maria, E.P.E.
Procuring entityLisboa, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.